DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1327-1333

  Zhu, Wei Guo ^a   Lakshmanan, Romola R ^a   Beal, Matthew D ^a   Otterson, Gregory A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DEPSIPEPTIDE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; ENZYME INHIBITOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; LYSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; DEACETYLATION; DOSE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACETYLATION; APOPTOSIS; AZACITIDINE; DNA MODIFICATION METHYLASES; DRUG SYNERGISM; ENZYME INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; LUNG NEOPLASMS; OLIGOPEPTIDES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035866353     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis
2. Properties of an acidic histone-binding protein fraction from cell nuclei. Selective precipitation and deacetylation of histones F2A1 and F3
3. DNA associated with hyperacetylated histone is preferentially digested by DNase I
4. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA
5. Histone acetylation in chromatin structure and transcription
6. Histone acetylation and transcriptional regulatory mechanisms
7. Retinoblastoma protein recruits histone deacetylase to repress transcription
8. Histone acetylation and cancer
9. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
10. Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells
11. Dietary fiber and the risk of colorectal cancer and adenoma in women
12. A p300/CBP-associated factor that competes with the adenoviral oncoprotein EIA
13. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
14. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export
15. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway
16. Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis
17. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
18. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells
19. Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells
20. How does DNA methylation repress transcription?
21. Methylated DNA and MeCp2 recruit histone deacetylase to repress transcription
22. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
23. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB
24. Optimization of calcium phosphate transfection for bovine chromaffin cells: Relationship to calcium phosphate precipitate formation
25. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine
26. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
27. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner
28. Chromatin
29. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
30. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
31. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites
32. IGF-II enhances trichostatin A-induced TGFβ1 and p21 (Waf1, Cip1, sdi1) expression in Hep3B cells
33. Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis
34. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells
35. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines
36. MBD2 is a transcriptional repressor belonging to the MeCPI histone deacetylase complex
37. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
38. The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression
39. Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene
40. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation
41. DNA methylation models histone acetylation
42. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
43. DNA methyltransferase Dnmt1 associates with histone deacetylase activity
44. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
45. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells